Viewing Study NCT06427434



Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06427434
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-23
First Post: 2024-05-19

Brief Title: Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Postnatal Low Back Pain
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Effect of Modified Lumbar Sustained Natural Apophyseal Glide on Low Back Pain in Postnatal Women
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study will be carried out to evaluate the effect of modified lumbar Sustained Natural Apophyseal Glide on low back pain in postnatal women
Detailed Description: In fact up to 75 of women who suffer from pregnancy-related back pain may continue to have pain after giving birth Women who experience LBP or pelvic girdle pain PGP at 3 months postpartum were found to be at higher risk for persistent or chronic LBP Of these women only 6 recover within 6-18 months after giving birth

A modified lumbar Sustained Natural Apophyseal Glide SNAG is an existing Mulligan mobilization technique performed with a combination of joint glide and physiological spinal movement The glide can be applied to the spinous processes facets or unilaterally over the transverse processes while the patient performs the active exercise

Few studies have been concerned with the effects of modified SNAGS on the lumbar spine So this study will be done to investigate its effect on low back pain in postnatal women aiming to improve their function to accomplish their daily living activities and reduce the side effects of medical treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None